» Authors » David Cibula

David Cibula

Explore the profile of David Cibula including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 256
Citations 5451
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Mirza M, Chase D, Slomovitz B, Christensen R, Novak Z, Black D, et al.
Future Oncol . 2024 Jul; 21(2):151-168. PMID: 38990090
No abstract available.
22.
Moro F, Pinto P, Chiappa V, Testa A, Alcazar J, Franchi D, et al.
Am J Obstet Gynecol . 2024 Jul; 231(6):632.e1-632.e14. PMID: 38969200
Background: A laparoscopy-based scoring system was developed by Fagotti et al (Fagotti or Predictive Index value (PIV)score) based on the intraoperative presence or absence of carcinomatosis on predefined sites. Later,...
23.
Vergote I, Gonzalez-Martin A, Fujiwara K, Kalbacher E, Bagameri A, Ghamande S, et al.
N Engl J Med . 2024 Jul; 391(1):44-55. PMID: 38959480
Background: Recurrent cervical cancer is a life-threatening disease, with limited treatment options available when disease progression occurs after first-line combination therapy. Methods: We conducted a phase 3, multinational, open-label trial...
24.
Fruhauf F, Cibula D, Kocian R, Zikan M, Dundr P, Jarkovsky J, et al.
Int J Gynecol Cancer . 2024 Jul; 34(7):985-992. PMID: 38950926
Objectives: To assess the diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer, to compare the outcomes for pelvic and para-aortic regions, and to...
25.
Kocian R, Kohler C, Bajsova S, Jarkovsky J, Zapardiel I, Di Martino G, et al.
Gynecol Oncol . 2024 Jun; 188:83-89. PMID: 38941963
Objective: To report the outcome of SLN staging in the SENTIX international prospective trial of SLN biopsy in patients with cervical cancer with an intensive ultrastaging protocol and central quality...
26.
Cibula D, Falconer H, Kohler C
N Engl J Med . 2024 May; 390(19):1832-1833. PMID: 38749048
No abstract available.
27.
Vergote I, Perez Fidalgo A, Valabrega G, Monk B, Herzog T, Cibula D, et al.
Int J Gynecol Cancer . 2024 Apr; 34(8):1283-1289. PMID: 38627035
Background: Patients with advanced/recurrent endometrial cancer have a poor prognosis and limited treatment options. Biomarkers such as tumor protein 53 () in endometrial cancer can integrate novel strategies for improved...
28.
Pinto P, Valentin L, Borcinova M, Wiesnerova M, Filip F, Burgetova A, et al.
Int J Gynecol Cancer . 2024 Mar; 34(6):871-878. PMID: 38531539
Background: In addition to the diagnostic accuracy of imaging methods, patient-reported satisfaction with imaging methods is important. Objective: To report a secondary outcome of the prospective international multicenter Imaging Study...
29.
Kasikova L, Rakova J, Hensler M, Lanickova T, Tomankova J, Pasulka J, et al.
Nat Commun . 2024 Mar; 15(1):2528. PMID: 38514660
Intratumoral tertiary lymphoid structures (TLSs) have been associated with improved outcome in various cohorts of patients with cancer, reflecting their contribution to the development of tumor-targeting immunity. Here, we demonstrate...
30.
Herzog C, Jones A, Evans I, Raut J, Zikan M, Cibula D, et al.
Cancer Res . 2024 Mar; 84(11):1898-1914. PMID: 38503267
Significance: The use of both cigarettes and e-cigarettes elicits cell- and exposure-specific epigenetic effects that are predictive of carcinogenesis, suggesting caution when broadly recommending e-cigarettes as aids for smoking cessation.